• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBHR130502A
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/25/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H6 - code b23: device has been requested, but has not been returned for evaluation.H6 - code c19: a review of manufacturing records verified that the lot involved in this complaint met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
On (b)(6) 2025, a patient underwent treatment for an aneurysmal popliteal artery.It was reported a v-18 boston 0.018" guidewire was used to advance a gore® viabahn® endoprosthesis with heparin bioactive surface viabahn device over a gore® dryseal flex introducer sheath.A 10mm x 15cm viabahn device was implanted in the distal popliteal artery without complication and successful implantation was achieved.Next, a 13mm x 5cm viabahn device was advanced and deployed.However, during post-dilation, it was realized the distal tip of the 13mm x 5cm viabahn delivery system had migrated into the peroneal artery.Using a snare, the distal tip was retrieved.The physician confirmed that no foreign material remained in the patient.After post dilation using a medtronic evercross balloon, the procedure was completed with good results.The patient did not experience any adverse consequences.As reported, the catheter appeared to have a clean break, suggesting the catheter may have been severed prior to insertion.No excessive force was applied during the procedure.The patient did not experience any adverse consequences.
 
Additional Manufacturer Narrative
Section h6 updated to reflect completion of investigation.Removed code d16 and added code d15.A review of manufacturing records verified that the lot involved in this complaint met all pre-release specifications.The device was requested but got discarded at the facility, therefore, not available for analysis.No clinical images enabling direct assessment of product performance were returned for evaluation.Cause of the reported event cannot be established based on the information reported to gore.Further information regarding this event was requested by gore, but no further information has been reported, therefore this investigation is considered complete.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
jazmin dela rosa
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key23336588
Report Number2017233-2025-06718
Device Sequence Number18094639
Product Code NIP
UDI-Device Identifier00733132646128
UDI-Public(01)00733132646128(17)280523
Combination Product (Y/N)Y
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P040037
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/03/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberVBHR130502A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/25/2025
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date10/20/2025
Supplement Report FDA Received Date12/03/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/25/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age82 YR
Patient SexMale
-
-